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Amyloid β-induced Upregulation 
of nav1.6 Underlies Neuronal 
Hyperactivity in Tg2576 Alzheimer’s 
Disease Mouse Model
Roselia ciccone1, Cristina franco1,2, ilaria piccialli1, Francesca Boscia1, Antonella Casamassa1, 
Valeria de Rosa  1, Pasquale cepparulo1, Mauro cataldi1, Lucio Annunziato3 & 
Anna pannaccione1
Hyperexcitability and alterations in neuronal networks contribute to cognitive impairment in Alzheimer’s 
Disease (AD). Voltage-gated sodium channels (NaV), which are crucial for regulating neuronal excitability, 
have been implicated in AD-related hippocampal hyperactivity and higher incidence of spontaneous 
non-convulsive seizures. Here, we show by using primary hippocampal neurons exposed to amyloid-β1–42 
(Aβ1–42) oligomers and from Tg2576 mouse embryos, that the selective upregulation of NaV1.6 subtype 
contributes to membrane depolarization and to the increase of spike frequency, thereby resulting in 
neuronal hyperexcitability. Interestingly, we also found that NaV1.6 overexpression is responsible for the 
aberrant neuronal activity observed in hippocampal slices from 3-month-old Tg2576 mice. These findings 
identify the NaV1.6 channels as a determinant of the hippocampal neuronal hyperexcitability induced by 
Aβ1–42 oligomers. The selective blockade of NaV1.6 overexpression and/or hyperactivity might therefore 
offer a new potential therapeutic approach to counteract early hippocampal hyperexcitability and 
subsequent cognitive deficits in the early stages of AD.
Alzheimer’s disease (AD) is the most frequent neurodegenerative disorder and the most common cause of 
dementia in the elderly. Although non-convulsive seizures and abnormal neuronal activity have been implicated 
in the development of cognitive deficits in AD patients, the mechanisms whereby this happens remain unclear1–3. 
Understanding the contribution of seizure-driven neuronal network dysfunction to AD may provide new insights 
into therapeutic strategies. Despite the appearance of seizures resulting from cortical neurodegeneration in AD 
patients has long been proposed as a marker of the late stages of the disease4, further studies have shown that the 
timing of seizure onset is not solely restricted to the late stages of AD. In fact, some findings suggest that epilep-
tiform activity occurring in the early stages accelerates AD onset and exacerbates cognitive deficits5,6. Moreover, 
AD patients with mutations in presenilin 1, presenilin 2, and amyloid precursor protein (APP), or with APP 
duplication have an increased risk of developing seizures6,7. Analogously, patients affected by mild cognitive 
impairment show greater hippocampal activation than cognitively intact individuals, as revealed by face-name 
associative memory tasks8.
Like human beings, transgenic mouse models of AD exhibit a variety of seizure types5,9–13. More important, 
in transgenic mouse models of AD, seizures and epileptiform activity seem to occur even before amyloid-β (Aβ) 
plaque deposition2,14. This new evidence has prompted researchers and clinicians to focus on seizures in the early 
stages of dementia5.
Moreover, the potential relationship between seizure-like activity and AD is also substantiated by evidence 
showing that soluble amyloid-β1–42 (Aβ1–42) promotes neuronal hyperexcitability. In particular, Tamagnini et al.15 
observed that acute application (2–5 hours) of soluble Aβ1–42 oligomers on hippocampal slices induce the increase 
of intrinsic excitability in CA1 pyramidal neurons, despite they did not observe any change in neuronal intrinsic 
1Division of Pharmacology, Department of Neuroscience, Reproductive and Dentistry Sciences, School of Medicine, 
Federico II University of Naples, Napoli, 80131, Italy. 2Division of Pharmacology, Department of Science and 
Technology, University of Sannio, Benevento, Italy. 3Fondazione IRCSS SDN Napoli, Naples, Italy. Roselia Ciccone 
and Cristina Franco contributed equally. Correspondence and requests for materials should be addressed to L.A. 
(email: lannunzi@unina.it) or A.P. (email: pannacio@unina.it)
Received: 30 January 2019
Accepted: 31 July 2019
Published: xx xx xxxx
open
2Scientific RepoRtS |         (2019) 9:13592  | https://doi.org/10.1038/s41598-019-50018-1
www.nature.com/scientificreportswww.nature.com/scientificreports/
properties, including membrane potential. Furthermore, a study by Ren and colleagues16, which also demon-
strated that Aβ1–42 oligomers trigger hyperexcitability in CA1 pyramidal neurons, hypothesized the involvement 
of Na+ channels in the increase of firing frequency upon acute Aβ1–42 application. In fact, the investigators showed 
that in the presence of riluzole, a non-selective antagonist of Na+ channels, the Aβ1–42-induced neuronal hyper-
excitation was significantly inhibited16.
The correlation between AD pathophysiology and increased neuronal excitability has been emphasized in 
a large amount of genetically modified mice overproducing the Aβ peptide and mimicking AD pathology9–11. 
Busche and colleagues14 found an increased number of hyperactive neurons in the hippocampal CA1 subregion 
of young APP/PS1 transgenic mice suggesting that soluble Aβ oligomers may directly induce neuronal hyper-
activity. Remarkably, these authors found that the treatment with a γ-secretase inhibitor by reducing soluble Aβ 
levels rescued the altered spontaneous activity of CA1 hippocampal neurons14. Notably, several lines of evidence 
indicate that Aβ1–42-induced neuronal hyperactivity may give rise to cognitive deficits and memory dysfunction 
in AD17,18. Indeed, neuronal hyperexcitation, along with the homeostatic responses to seizure activity, contributes 
to malfunction of the hippocampal circuitry, which specifically causes memory impairment17,18.
Alterations in voltage-gated sodium channel (NaV) physiology have been implicated in the dysregulation of 
neuronal excitability19–22. In fact, NaV channels contribute to the initiation and propagation of action potentials 
and are critical for neuronal excitability23,24. In mammals, nine different genes encode the nine monomeric single 
pore-forming α-subunits of NaV channels (NaV1.1 to NaV1.9)25. Among them, NaV1.1, NaV1.2, and NaV1.6 sub-
types are expressed in the adult brain26. The distribution of NaV subtypes determines their specific neuronal func-
tions27. For instance, whereas NaV1.1 is primarily localized in the neuronal somata of GABAergic neurons28–30, 
NaV1.2 is preferentially expressed in unmyelinated fibers31 and neocortical somatostatin-positive inhibitory neu-
rons but not in parvalbumin-positive neurons32. Regarding NaV1.6, which is the most densely expressed sodium 
channel in the adult central nervous system, several studies showed that it is expressed in a variety of neuronal 
cells including Purkinje cells, motor neurons, pyramidal neurons, granule neurons, glial cells, and Schwann 
cells33. In addition, it is expressed along the nodes of Ranvier, where it facilitates saltatory conduction34. More 
important, since it is highly expressed along the axon initial segment35,36, where it plays a significant role in ini-
tiating the action potential37, the role of NaV1.6 subtype in the etiology of neuronal hyperexcitability has been 
extensively investigated21,22. On the other hand, despite these evidence bring out the NaV1.6 channel as a possible 
player in AD pathogenesis, its role needs to be elucidated.
In this scenario, we hypothesized that NaV1.6 α-subunits could be a crucial mediator of the neuronal hyperex-
citability induced by Aβ1–42 oligomers. To clarify the possible link between Na+ currents and the changes in neu-
ronal excitability occurring in AD and to address NaV1.6 involvement, we set out to answer several questions. In 
particular, we investigated whether: (1) NaV1.6 protein expression and current density were altered upon Aβ1–42 
exposure, (2) changes in spike frequency and membrane depolarization occurred in hippocampal neurons after 
Aβ1–42 exposure, (3) hippocampal neurons obtained from AD-related Tg2576 mouse embryos displayed changes 
in the protein expression of NaV1.6, in spike frequency, in membrane depolarization, in current density of NaV1.6, 
(4) NaV1.6 silencing or anisomycin treatment could revert the electrophysiological effects elicited by Aβ1–42, and 
(5) these biochemical changes were confirmed by immunofluorescence images obtained by confocal microscopy. 
Moreover, we further explored the involvement of NaV1.6 upregulation in neuronal hyperexcitability in the hip-
pocampus of Tg2576 mice, a widely used mouse model to study Aβ pathology, in the early stages of AD.
Answering these questions could shed light on the mechanisms involved in seizure-driven neuronal dysfunc-
tion in AD and lead hopefully to new promising perspectives aimed at slowing, or even blocking, the progression 
of cognitive decline.
Results
Aβ1–42 exposure selectively upregulated NaV1.6 protein expression and activity in primary hip-
pocampal neurons. After twenty-four hours of Aβ1–42 exposure, Na+ currents were significantly increased in 
a concentration dependent manner, reaching a maximal increase at 5 μM as revealed by patch clamp experiments 
in whole cell configuration (Fig. 1A–C). By contrast, 5 μM of the reverse Aβ peptide (Aβ42-1) did not induce any 
significant modification of Na+ currents (Fig. 1B). Interestingly, at forty-eight hours after treatment, the effect of 
Aβ1–42 on Na+ currents, albeit still significantly increased in comparison with untreated neurons, was reduced 
(Fig. 1C), likely suggesting that the effect of a single treatment was counteracted by the neuronal capability to 
clear Aβ1–42 over time or by the further aggregation in to fibrils and subsequent loss of the effect.
In addition, both in Aβ1–42-treated hippocampal neurons and in control hippocampal neurons, Na+ currents 
were completely blocked by the extracellular application of the sodium channel blocker tetrodotoxin (TTX, 
50 nM) (Supplementary Fig. 1A,B). Importantly, electrophysiological patch-clamp recordings revealed that rest-
ing membrane potential was more positive (Fig. 1D,E) and the firing frequency was higher (Fig. 1F) in primary 
hippocampal neurons exposed to Aβ oligomers (5 μM, 24 h) than in control neurons.
Western blot analyses showed that Aβ1–42 oligomers (5 µM), which were found to accumulate intracellularly 
after 24 hours (Supplementary Fig. 2B, left), selectively increased NaV1.6 α1 subunit protein expression in pri-
mary hippocampal neurons as compared to control neurons (Fig. 2C). Indeed, Aβ1–42 oligomer exposure failed 
to modify the protein expression of the other two brain α1 subunits, NaV1.1 and NaV1.2 (Fig. 2A,B). The con-
tribution of NaV1.6 to Na+ current upregulation in primary hippocampal neurons exposed to Aβ1–42 oligomers 
was further tested by silencing NaV1.6 with a selective small interfering RNA (siRNA) in the presence or in 
the absence of Aβ1–42 oligomers. This siRNA not only significantly downregulated NaV1.6 protein expression 
(Fig. 2G), but also completely prevented the upregulation of Na+ currents in primary hippocampal neurons after 
Aβ1–42 oligomer exposure (5 µM, 24 h) (Fig. 2E,F). Similarly, siNaV1.6 significantly reduced Na+ currents in con-
trol neurons (Fig. 2D,F).
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Figure 1. Effect of Aβ1–42 exposure on Na+ currents in primary hippocampal neurons at 10–12 DIV. (A) 
Representative traces of Na+ currents recorded in primary hippocampal neurons under control conditions and 
after 24 h of 0.1 μM, 1 μM and 5 μM Aβ1–42. (B) Normalization of Na+ current densities at −20 mV recorded 
from primary hippocampal neurons under control conditions and after 24 h of 0.1 μM, 1 μM, 5 μM Aβ1–42 and 
5 μM Aβ42-1. The number of cells used for each experimental condition is noted on the bars, values are expressed 
as percentage mean ± SEM of 3 independent experimental sessions. *p < 0.05 versus control, ***p < 0.001 
versus control, ^p < 0.05 versus 0.1 μM, #p < 0.001 versus 0.1 and 1 μM. (C) Normalization of Na+ current 
densities at −20 mV recorded from primary hippocampal neurons under control conditions and after 1 h, 
12 h, 24 h, and 48 h of 5 μM Aβ1–42. The number of cells used for each experimental condition is noted on the 
bars, values are expressed as percentage mean ± SEM of 3 independent experimental sessions. ***p < 0.001 
versus control, ^p < 0.001 versus 1 h, #p < 0.001 versus 1 h and 12 h, §p < 0.001 versus 24 h. (D) Representative 
current tracings recorded in the gap-free mode under control conditions and after 5 μM Aβ1–42 (24 h) in primary 
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To reinforce the results obtained with siNaV1.6, we also used a pharmacological approach. In particular, we 
used anisomycin, a Streptomyces griseolus antibiotic that, by promoting p38 mitogen-activated protein (MAP) 
kinase activation, induces the selective endocytosis of NaV1.6 channels38,39. Notably, although this antibiotic is 
known to also inhibit protein synthesis and activate other MAP kinases40, it is commonly used in order to activate 
p38 MAP kinase, a mechanism occurring within the first 30 min after treatment, before the activation of other 
pathways41,42.
Similarly to NaV1.6 silencing, the treatment with anisomycin reduced Na+ currents (Fig. 2F ) in primary hip-
pocampal neurons, thus preventing the electrophysiological changes elicited by Aβ1–42 oligomers, as evidenced by 
Na+ currents quantification (Fig. 2D,E).
Primary hippocampal neurons from AD-related Tg2576 mice displayed the selective upregula-
tion of protein expression and activity of NaV1.6 channels. Several lines of evidence demonstrated 
that primary cortical neurons from Tg2576 mouse embryos recapitulate the in vivo localization and accumulation 
of Aβ1–42 over time in culture43,44. Therefore, to understand the effects of intracellular Aβ1–42 oligomers on NaV1.6 
channels and their implication in hippocampal hyperexcitability, we isolated primary hippocampal neurons from 
wild type (WT) and Tg2576 mouse embryos. Then, we confirmed the presence of Aβ1–42 oligomers in primary 
hippocampal neurons from Tg2576 mice. In particular, we detected an intense band of ~12 kDa corresponding to 
Aβ1–42 trimers (Supplementary Fig. 2B, right).
Electrophysiological patch-clamp recordings showed that Na+ currents were significantly increased in pri-
mary Tg2576 hippocampal neurons compared to WT hippocampal neurons (Fig. 3A,B). Western blot experi-
ments revealed a higher expression of NaV1.6 channel α1 subunits in hippocampal neurons from Tg2576 mice 
than in their WT littermates (Fig. 3E). Conversely, there was no difference in the expression of NaV1.1 and NaV1.2 
α1 subunits (Fig. 3C,D, respectively), supporting the hypothesis that NaV1.6 was selectively involved in Aβ1–
42-induced Na+ current upregulation in Tg2576 hippocampal neurons.
Confocal studies showed NaV1.6 immunoreactivity in both the soma and neuronal processes of both WT and 
Tg2576 pyramidal neurons, which are the most abundant neuronal type in our cultures (Fig. 3F). Furthermore, 
NaV1.6 immunostaining clearly appeared in a punctuate labelling in both WT and Tg2576 primary hippocampal 
neurons, thus confirming previous observations by Akin and colleagues45, which found that somatic NaV1.6 
channels localized to nanoclusters at the neuronal surface.
Anisomycin treatment reverted upregulation of NaV1.6 currents, spike frequency, membrane 
depolarization, spontaneous action potentials and reduced NaV1.6 immunofluorescence signal 
in primary hippocampal neurons from AD-related Tg2576 mice. Like primary hippocampal neu-
rons treated with Aβ1–42 oligomers, hippocampal neurons from Tg2576 mice displayed a significant membrane 
depolarization and an increase in spike frequency in comparison to WT neurons (Fig. 4, top of panel D, E and 
F). Importantly, both NaV1.6 silencing and anisomycin treatment significantly reduced Na+ currents in Tg2576 
hippocampal neurons (Fig. 4B,C). siNaV1.6 and anisomycin treatment significantly reduced Na+ currents also in 
WT hippocampal neurons (Fig. 4A,C). Moreover, both NaV1.6 silencing and anisomycin treatment counteracted 
the increase in spike frequency and membrane depolarization in Tg2576 hippocampal neurons (Fig. 4D–F). In 
addition, we evaluated the involvement of enhanced NaV1.6 channels in the generation of spontaneous action 
potentials (AP) in primary hippocampal neurons obtained from WT and Tg2576 mice. When spontaneous APs 
were recorded, Tg2576 hippocampal neurons showed APs with a higher amplitude and frequency than those 
recorded in WT hippocampal neurons (Supplementary Fig. 3A–C). Interestingly, Tg2576 hippocampal neurons 
exposed to anisomycin displayed a significant reduction in the amplitude and in the frequency of spontaneous 
APs when compared to Tg2576 hippocampal neurons in the absence of anisomycin (Supplementary Fig. 3A–C).
Confocal imaging to visualize double-labeling of NaV1.6 channels with the neuron-specific microtubule 
associated protein (MAP2) revealed a NaV1.6 punctuated staining throughout the neuropil and soma of WT 
hippocampal neurons (Fig. 5A). In addition, NaV1.6 immunofluorescence signal depicted a more pronounced 
perikaryal staining in Tg2576 hippocampal neurons (Fig. 5A, d-f) when compared to WT neurons (Fig. 5A, a-c). 
Interestingly, anisomycin treatment reduced the increase in NaV1.6 immunoreactivity in Tg2576 hippocampal 
neurons (Fig. 5A, g-i). In particular, the quantitative analysis performed within the neuronal soma indicated that 
the number of NaV1.6 positive-puncta was significantly upregulated in Tg2576 hippocampal neurons, whereas it 
was significantly downregulated in Tg2576 hippocampal neurons treated with anisomycin (Fig. 5B).
The expression of NaV1.6 channel in hippocampal neurons of young Tg2576 mice is higher than 
in neurons from WT littermates. Tg2576 mice, a widely used transgenic model to study AD pathol-
ogy, start to accumulate intracellular small Aβ oligomers at 3 months of age and this phenomenon is believed 
hippocampal neurons. (E) Quantification of Aβ1–42 effects on spike frequency under control conditions and 
after 5 μM Aβ1–42 (24 h) in primary hippocampal neurons. The number of cells used for each experimental 
condition is noted on the bars, values are expressed as percentage mean ± SEM of 3 independent experimental 
sessions. ***p < 0.001 versus control. (F) Quantification of Aβ1–42 effects on membrane potential under control 
conditions and after 5 μM Aβ1–42 (24 h) in primary hippocampal neurons. The number of cells used for each 
experimental condition is noted on the bars, values are expressed as percentage mean ± SEM of 3 independent 
experimental sessions. ***p < 0.001 versus control.
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Figure 2. Effect of Aβ1–42 exposure on NaV1.6 protein expression and activity in primary hippocampal neurons 
at 10–12 DIV. (A) Representative western blot (top) and densitometric quantification (bottom) of NaV1.1 
protein expression in primary hippocampal neurons under control conditions and after 5 μM Aβ1–42 (24 h). 
Values are expressed as mean ± SEM of 3 independent experimental sessions. (B) Representative western 
blot (top) and densitometric quantification (bottom) of NaV1.2 protein expression in primary hippocampal 
neurons under control conditions and after 5 μM Aβ1–42 (24 h). Values are expressed as mean ± SEM of 3 
independent experimental sessions. (C) Representative western blot (top) and densitometric quantification 
(bottom) of NaV1.6 protein expression in primary hippocampal neurons under control conditions and after 
5 μM Aβ1–42 (24 h). Values are expressed as mean ± SEM of 3 independent experimental sessions. **p < 0.01 
versus control. (D) Representative traces of Na+ currents recorded under control conditions, in the presence 
of siNaV1.6 (50 nM; 48 h) and in the presence of anisomycin (10 μM; 30 min) in primary hippocampal 
neurons. (E) Representative traces of Na+ currents recorded after 5 μM Aβ1–42 (24 h) alone, in the presence of 
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to be responsible for the appearance of precocious learning and memory deficits46,47 and for the high seizure 
susceptibility48.
To investigate whether the early Aβ oligomers accumulation in Tg2576 mice also enhanced NaV1.6 channel 
expression and activity, we performed both western blot and immunohistochemical experiments on the hip-
pocampus of 3-month-old Tg2576 mice.
We first confirmed the presence of small Aβ1–42 oligomers, detectable as ~12 kDa band identified as Aβ1–42 tri-
mers, in the hippocampus of 3-month-old Tg2576 mice, whereas they were completely absent in the hippocam-
pus of WT littermates (Supplementary Fig. 2C).
We analyzed the protein expression of the three neuronal α1 subtypes NaV1.1, NaV1.2 and NaV1.6 in the 
hippocampus of both 3-month-old WT and Tg2576 mice. Notably, we found that protein expression of NaV1.6 
but not of NaV1.1 and NaV1.2 was significantly higher in Tg2576 than in WT hippocampal lysates (Fig. 6A–C).
Accordingly, the confocal double immunofluorescence analysis of NaV1.6 channels with the neuron-specific 
protein MAP2 showed a more intense NaV1.6 immunoreactivity within neurons of the CA1 hippocampal region 
of Tg2576 mice (Fig. 6D, d–f) in comparison to WT littermates (Fig. 6D, a–c). Furthermore, NaV1.6 immunosig-
nal in the CA1 pyramidal neurons of both Tg2576 and WT mice exhibited the characteristic punctuate labelling 
of the NaV1.6 subtype along neuronal soma and dendrites (Fig. 6D). The quantitative analysis performed within 
the neuronal soma indicated that the number of NaV1.6 positive-puncta was significantly upregulated in the CA1 
hippocampal neurons of Tg2576 mice in comparison to WT littermates (Fig. 6E).
The epileptiform response to 4-aminopyridine is enhanced in hippocampal slices from Tg2576 
mice and is selectively reduced by anisomycin. Since our previous patch-clamp experiments had 
revealed that the upregulation of NaV1.6 activity contributed to the higher excitability observed at the single cell 
level in Tg2576 hippocampal neurons, we wondered whether such phenomenon could also impact neuronal 
network activity in Tg2576 hippocampus. To answer this question, we compared the extracellular field poten-
tial activity elicited by the pro-convulsivant drug 4-aminopyridine (4-AP, 50 μM) in acute hippocampal slices 
obtained from 3-month-old WT and Tg2576 slices.
As expected, spontaneous epileptiform activity was observed neither in WT nor in Tg2576 slices when they 
were superfused with artificial cerebrospinal fluid (ACSF) without 4-AP (Fig. 7, top of panels A and B) but it 
appeared when 4-AP was added to the superfusing solution (Fig. 7, middle of panels A and B). Notably, a sig-
nificantly higher number of electrical discharges, occurring with similar amplitude but shorter intervals, was 
observed in Tg2576 in comparison to WT hippocampal slices (Fig. 7, middle of panels A and B; Fig. 7C).
When anisomycin (100 μM) was added to the 4-AP-containing solution, the discharge frequency significantly 
decreased in the slices from Tg2576 mice (Fig. 7, bottom of panel B; Fig. 7D). Interestingly, this drug was much 
less effective in WT slices (Fig. 7, bottom of panel A; Fig. 7D), suggesting that NaV1.6 channels were specifically 
involved in maintaining the hyperexcitability of Tg2576 mice.
Discussion
The present study demonstrates that the NaV1.6 channel is a crucial player in mediating the increase in spike fre-
quency and hippocampal hyperexcitability induced by Aβ1–42. The concept that Aβ1–42 oligomers trigger hyperex-
citability has been widely demonstrated by several studies using soluble Aβ oligomers and in a number of mouse 
models mimicking amyloid pathology.
To further explore the biological actions of Aβ1–42 oligomers on hippocampal neurons and to investigate the 
involvement of Na+ current alterations in the Aβ1–42-induced hyperexcitability, here we used two in vitro mod-
els mimicking amyloid pathology: primary cultures of hippocampal neurons from WT mice treated with syn-
thetic Aβ1–42 oligomers for 24 hours, and primary cultures of hippocampal neurons from Tg2576 mice, which 
endogenously produce Aβ1–42 peptides that accumulate over time in culture. Importantly, western blot analyses 
showed that primary hippocampal neurons treated with the oligomeric synthetic preparation accumulate Aβ1–42 
intracellularly, thus confirming that Aβ1–42 oligomers are uptaken into the neuron from the culture medium 
(Supplementary Fig. 2B). Remarkably, in both primary hippocampal neurons exposed to Aβ1–42 and Tg2576 
hippocampal neurons, we observed an intense band of ~12 kDa corresponding to Aβ1–42 trimers (Supplementary 
Fig. 2B), which have been identified as the smallest Aβ1–42 specie able to impair synaptic plasticity and memory 
performance49,50. More important, we found that, along with the intracellular accumulation of Aβ1–42 oligomers, 
NaV1.6 protein expression and functional activity were selectively increased in both the in vitro models. In addi-
tion, we demonstrated that NaV1.6 upregulation is also responsible for the hyperexcitability of CA1 hippocampal 
neurons in 3-month-old Tg2576 mice, which display precocious hippocampal accumulation of low-weight Aβ1–42 
oligomers, early learning deficits and cognitive impairment51.
The hypothesis that NaV1.6 subtype could play an important role in Aβ1–42-induced neuronal hyperexcitability 
was tested by using NaV1.6 siRNA and anisomycin treatment. Importantly, both NaV1.6 silencing and anisomycin 
siNaV1.6 (50 nM; 48 h) and in the presence of anisomycin (10 μM; 30 min) in primary hippocampal neurons. 
(F) Normalization of Na+ current densities, at −20 mV, represented in panel D and E. The number of cells 
used for each experimental condition is noted on the bars, values are expressed as percentage mean ± SEM 
of 3 independent experimental sessions. ***p < 0.001 versus control, #p < 0.001 versus control Aβ1–42. (G) 
Representative western blot of NaV1.6 protein expression (top) in the presence of siNaV1.6 (50 nM; 48 h) in 
primary hippocampal neurons at 12 DIV. Quantification of siNav1.6 inhibition in primary hippocampal 
neurons (bottom). Values are expressed as percentage mean ± SEM of 3 independent experimental sessions. 
**p < 0.01 versus control neurons.
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Figure 3. Expression and activity of NaV1.6 channels in Tg2576 primary hippocampal neurons. (A) 
Representative traces of Na+ currents recorded in WT and Tg2576 primary hippocampal neurons after 8 and 
12 DIV. (B) Normalization of Na+ current densities at −20 mV represented in panel A. Values are expressed 
as mean ± SEM of current densities of 3 independent experimental sessions. The number of cells used for each 
experimental condition is noted on the bars, values are expressed as percentage mean ± SEM of 3 independent 
experimental sessions. ***p < 0.001 versus WT. (C) Representative western blot (top) and densitometric 
quantification (bottom) of NaV1.1 protein expression in WT and Tg2576 primary hippocampal neurons after 12 
DIV. Values are expressed as mean ± SEM of 3 independent experimental sessions. (D) Representative western 
blot (top) and densitometric quantification (bottom) of NaV1.2 protein expression in WT and Tg2576 primary 
hippocampal neurons after 12 DIV. Values are expressed as mean ± SEM of 3 independent experimental sessions. 
(E) Representative western blot (top) and densitometric quantification (bottom) of NaV1.6 protein expression 
in WT and Tg2576 primary hippocampal neurons after 12 DIV. Values are expressed as mean ± SEM of 3 
independent experimental sessions. **p < 0.01 versus WT. (F) Representative confocal images displaying NaV1.6 
distribution in WT (left) and Tg2576 (right) primary hippocampal neurons after 12 DIV. Scale bars: 20 μm.
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Figure 4. Effect of siNaV1.6 and anisomycin on NaV1.6 protein expression and activity in Tg2576 primary 
hippocampal neurons. (A) Representative traces of Na+ currents recorded in WT primary hippocampal 
neurons after 12 DIV under control conditions, in the presence of siNaV1.6 (50 nM; 48 h) and in the presence 
of anisomycin (10 μM; 30 min). (B) Representative traces of Na+ currents recorded in Tg2576 primary 
hippocampal neurons after 12 DIV under control conditions, in the presence of siNaV1.6 (50 nM; 48 h) and in 
the presence of anisomycin (10 μM; 30 min). (C) Normalization of Na+ current densities at −20 mV represented 
in panel A and B. The number of cells used for each experimental condition is noted on the bars, values are 
expressed as percentage mean ± SEM of 3 independent experimental sessions. **p < 0.01 versus control WT, 
***p < 0.001 versus control WT, #p < 0.001 versus control Tg2576. (D) Representative current tracings recorded 
in the gap-free mode in WT and Tg2576 hippocampal neurons after 12 DIV under control conditions, in the 
presence of siNaV1.6 (50 nM; 48 h) and in the presence of anisomycin (10 μM; 30 min). (E) Quantification of 
spike frequency recorded in WT and Tg2576 hippocampal neurons after 12 DIV under control conditions, in 
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treatment significantly reduced Na+ currents and prevented the electrophysiological changes elicited by Aβ1–42 
oligomers, including the increase of spike frequency and membrane depolarization, thereby highlighting the 
specific involvement of NaV1.6 subtype in Aβ1–42-induced neuronal hyperexcitability. In addition, overexpressed 
Nav1.6 channels may be involved in the generation of spontaneous APs since anisomycin exposure significantly 
reduced the amplitude and the frequency of spontaneous APs in Tg2576 hippocampal neurons. Importantly, our 
results are in line with previous observations demonstrating the crucial role of NaV1.6 channels in hyperexcita-
bility during epileptogenesis22,52,53.
However, the mechanisms by which Aβ1–42 oligomers increase NaV1.6 activity in hippocampal neurons are 
still unknown. The selective increase of NaV1.6 subtype protein expression would suggest either an increased gene 
transcription and/or a reduced degradation of channel protein or mRNA. In this regard, it is worth mentioning 
that other groups of investigators demonstrated that Aβ1–42 oligomers can induce a downregulation of the ubiqui-
tin system and decreased protein degradation in several AD mouse models54.
It is well known that Aβ1–42 oligomers are able to interact with the neuronal plasma membrane and target 
many specific transmembrane proteins, such as channels and receptors55,56. However, a direct action of Aβ1–42 
oligomers on NaV1.6 channels seems unlikely in our system for at least two reason: first, it took about twenty-four 
hours for Aβ1–42 oligomers to maximally increase NaV1.6 currents and, second, a significant increase in channel 
expression also occurred at that time.
Another aspect that deserves consideration is that the cytosolic domain of APP directly interacts with NaV1.6 
channels and promotes their translocation to the cell membrane thus enhancing NaV1.6 cell surface localization57. 
In fact, this APP-mediated mechanism might come in addition to the effect mediated by Aβ1–42 on NaV1.6 hyper-
function since both proteins are overexpressed in Tg2576 hippocampal neurons.
A crucial issue that remains to be addressed is the relation between alterations of neuronal activity and the 
behavioral and cognitive symptoms in AD. Importantly, in several mouse models of AD overexpressing APP or 
harboring mutant APP it has been demonstrated that the alteration of neuronal activity and consequent spon-
taneous non-convulsive seizures contribute to cognitive impairments7,17. However, whether the abnormal brain 
activity occurs before, concomitantly or after the onset of memory dysfunctions needs to be further investigated. 
Nonetheless, several studies reported network hypersynchrony and precocious hyperexcitability in Tg2576 mice 
before the onset of memory deficits48,58. Notably, these transgenic mice, which display the early intraneuronal 
accumulation of Aβ1–42 oligomers59,60 and precocious learning and memory deficits in the early stages of dis-
ease46,47,61, appear as a mouse model particularly suitable to investigate these processes.
Our findings on 3-month-old Tg2576 mice revealed that NaV1.6 plays a crucial role in mediating the neuronal 
hyperexcitability observed in these mice. In particular, we demonstrated the involvement of NaV1.6 subtype by 
inducing its internalization through anisomycin treatment during extracellular measurement of simultaneous 
field potentials in the presence of 4-AP. Importantly, despite anisomycin is known to induce different mech-
anisms, including the inhibition of protein synthesis, we used this pharmacological tool in a time window of 
30–60 minutes, only in order to promote p38 MAP kinase activation and, meanwhile, to avoid non-specific effects 
of anisomycin. In particular, anisomycin selectively activates p38 MAP-kinase after 15 minutes of exposure, and 
this biochemical pathway is specific for the internalization of NaV1.6 channels, without affecting the other NaV 
subtypes38. Moreover, despite anisomycin could exert non-specific effects due to the inhibition of protein syn-
thesis, we can exclude this phenomenon since protein synthesis inhibition should not occur during the short 
time-intervals that we used in our experiments38.
Interestingly, anisomycin application significantly reduced 4-AP-induced seizure-like activity in Tg2576 acute 
hippocampal slices, but not in WT hippocampal slices. Several hypotheses could explain the different responsive-
ness of Tg2576 and WT slices to anisomycin application. A likely explanation to consider is related to the mech-
anism of action of anisomycin, which has been demonstrated to consist of a Nedd4-dependent internalization 
of NaV1.6 channel39. Indeed, it has been demonstrated that the expression of Nedd4-1 is constitutively increased 
in AD and in Tg2576 mice62,63, thus rendering anisomycin more effective in these mice. A second hypothesis 
to explain this seeming discrepancy is that the subcellular distribution of NaV1.6 channels could be altered in 
Tg2576 mice. Indeed, since it has been demonstrated that APP directly binds to NaV1.6 channels hence increasing 
their density in neuronal plasma membrane57, it is tempting to speculate that when APP is overexpressed, as in 
Tg2576 mice, it could disturb the normal subcellular distribution of NaV1.6, thereby rendering these channels 
more relevant for the responsiveness to 4-AP. Despite we believe that it is an aspect that deserves consideration, 
we did not investigate whether this distribution pattern is anyhow modified in Tg2576 mice for instance by mis-
placing a higher fraction of NaV1.6 channels in regions presumably critical for the response to 4-AP such as the 
dendritic spines or presynaptic terminals. Subtle functional differences ensuing from the different subcellular 
location of NaV1.6 channels could not be detectable when whole cell patch clamp recordings are performed but 
could have a significant impact on a coordinated network response such as in extracellular filed experiments. In 
the presence of siNaV1.6 (50 nM; 48 h) and in the presence of anisomycin (10 μM; 30 min). The number of cells 
used for each experimental condition is noted on the bars, values are expressed as percentage mean ± SEM 
of 3 independent experimental sessions. ***p < 0.001 versus WT. #p < 0.001 versus control Tg2576. (F) 
Quantification of membrane depolarization recorded in WT and Tg2576 primary hippocampal neurons after 
12 DIV under control conditions, in the presence of siNaV1.6 (50 nM; 48 h) and in the presence of anisomycin 
(10 μM; 30 min). The number of cells used for each experimental condition is noted on the bars, values are 
expressed as percentage mean ± SEM of 3 independent experimental sessions. **p < 0.01 versus WT. #p < 0.001 
versus control Tg2576
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addition, it cannot be excluded that, unlike the single neurons, a coordinated neuronal network could enact com-
pensatory responses to the disappearance of NaV1.6 channels from the plasma membrane induced by anisomycin.
As regard as the involvement of NaV channels in AD pathology, several studies have also shown the implication 
of NaV1.1 hypofunction in the alteration of hippocampal neuronal networks occurring in AD64,65. In particular, it 
Figure 5. Immunocytochemical analysis of NaV1.6 protein expression after anisomycin treatment in Tg2576 
primary hippocampal neurons at 12 DIV. (A) Confocal double immunofluorescence images displaying NaV1.6 
(green) and MAP2 (red) distribution in WT (a-c) and Tg2576 primary hippocampal neurons in the absence 
(d-f) or in the presence (g-i) of anisomycin. Scale bars in a-i: 20 μm. (B) Quantitative analyses of NaV1.6-
positive puncta within the soma of WT and Tg2576 primary hippocampal neurons in the absence or in the 
presence of anisomycin. Scale bars: 5 μm. Data are expressed as mean ± SEM of values obtained from 20 cells 
per group in 3 independent experimental sessions. **p < 0.01 versus WT; #p < 0.001 versus Tg2576.
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Figure 6. Evaluation of NaV1.6 protein expression in the hippocampus of 3-month-old WT and Tg2576 mice. 
(A) Representative western blot (top) and densitometric quantification (bottom) of NaV1.1 protein expression in 
the hippocampus of WT and Tg2576 mice. Values are expressed as mean ± SEM of 3 independent experimental 
sessions. (B) Representative western blot (top) and densitometric quantification (bottom) of NaV1.2 protein 
expression in the hippocampus of WT and Tg2576 mice. Values are expressed as mean ± SEM of 3 independent 
experimental sessions. (C) Representative western blot (top) and densitometric quantification (bottom) of 
NaV1.6 protein expression in the hippocampus of WT and Tg2576 mice. Values are expressed as mean ± SEM of 
3 independent experimental sessions. **p < 0.01 versus WT. (D) Confocal double immunofluorescence images 
displaying NaV1.6 (green) and MAP2 (red) distribution in the hippocampus of 3-month-old WT (a-c) and 
Tg2576 mice (d-f). Scale bars in a-f: 20 μm. (E) Quantitative analyses of NaV1.6-positive puncta within the soma 
of WT and Tg2576 neurons in the hippocampus of 3-month-old mice. Values are expressed as mean ± SEM of 3 
independent experimental sessions. **p < 0.01 versus WT.
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Figure 7. Effect of anisomycin on epileptiform activity elicited by 4-AP in acute hippocampal slices of 
3-month-old WT and Tg2576 mice. (A) Representative traces of extracellular field recordings in acute 
hippocampal slices of 3-month-old WT mice before 4-AP addition (top), in the presence of 50 μM 4-AP alone 
(middle) and in the presence of 100 μM anisomycin (bottom). (B) Representative traces of extracellular field 
recordings in acute hippocampal slices of 3-month-old Tg2576 mice before 4-AP addition (top), in the presence 
of 50 μM 4-AP alone (middle) and in the presence of 100 μM anisomycin (bottom). (C) Quantification of 
frequency (Hz), interval (sec), and amplitude (mV) of extracellular field recordings in acute hippocampal slices 
of 3-month-old WT and Tg2576 mice under control conditions. *p < 0.05 versus WT (D) Quantification of 
4-AP-induced epileptiform activity, as frequency (Hz), interval (sec), and amplitude (mV), in the presence of 
100 μM anisomycin, in acute hippocampal slices of 3-month-old WT and Tg2576 mice. Values are expressed 
as a percentage of basal values measured in the presence of 4-AP alone before starting the perfusion with 
anisomycin. *p < 0.05 versus WT.
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has been recently demonstrated that in mice overexpressing APP there is a decrease of NaV1.1 protein expression 
and activity in inhibitory parvalbumin-positive interneurons, which induces the impairment of inhibitory func-
tion and subsequent aberrant neuronal activity66. More important, NaV1.1-null mice exhibit spontaneous seizures 
and significant reduction in Na+ currents in isolated GABAergic interneurons, but not in pyramidal cells from 
hippocampus, suggesting that loss of NaV1.1 might specifically decrease inhibitory function, thereby prompting 
hyperexcitability67. It is worth noting that NaV1.1 subtype is expressed only in the AIS of GABAergic interneurons 
of dentate gyrus68, whereas NaV1.6 subtype has greater expression in CA1, which is the main excitatory region 
of the hippocampus receiving glutamatergic input from the CA3 and entorhinal cortex69,70. Thus, despite having 
demonstrated the relevant role of the NaV1.6 subtype in hippocampal neuronal hyperexcitability induced by 
Aβ1–42 accumulation, we cannot rule out the likelihood that other NaV subtypes may play a different role in this 
process through distinct mechanisms depending on their regional and cellular expression.
Collectively, our results highlight the NaV1.6 subtype as one of the determinants of hippocampal neuronal 
hyperexcitability induced by Aβ1–42 oligomers. Therefore, the selective blockage of this channel could represent an 
alternative strategy and a promising target to counteract AD-related network dysfunction and cognitive decline.
Methods
Animals. Animals were handled in accordance with the International Guidelines for Animal Research and 
the experimental protocol was approved by the Animal Care and Use Committee of “Federico II” University of 
Naples. Heterozygous male Tg2576 mice and WT littermates were purchased from a commercial source [B6;SJL-
Tg(APPSWE)2576Kha, model 1349, Taconic, Hudson, NY]. Tg2576 mice are a well-established AD-related 
mouse model carrying the human APP Swedish 670/671 mutation (K670N e M671L)71.
Genotyping: PCR analysis. Genomic DNA from mouse tails was isolated by salt precipitation. In brief, tails 
were cut off and incubated with tail digestion buffer (50 mM Tris-HCl pH 8.0, 100 mM EDTA pH 8.0, 100 mM 
NaCl, 1% SDS) supplemented with proteinase K from tritirachium album (Sigma Aldrich, Milan, Italy) at a final 
concentration of 0.5 mg/ml. Embryonic brain tissue was harvested during cerebral dissection and frozen immedi-
ately upon collection. Frozen brain tissue samples were then thawed and homogenized with TRI-reagent (Sigma 
Aldrich, Milan, Italy). Subsequently, one volume of phenol:chloroform:isoamyl alcohol (25:24:1) was added 
to each sample. After DNA precipitation with 100% ethanol, the sample was centrifuged at 4 °C for 30 min at 
16,000 × g to pellet the DNA. After ethanol removal, the DNA pellet was dried at room temperature for 5–10 min. 
Finally, it was resuspended in Tris-EDTA buffer by pipetting up and down 30–40 times. The following prim-
ers were used to amplify the DNA region with human APP Swedish mutation on both types of genomic DNA: 
5′-CTGACCACTCGACCAGGTTCTGGGT-3′ and 5′GTGGATAACCCCTCCCCC AGCCTAGACCA-3′ 
(Eurofins Genomics, Ebersberg, Germany). The amplification protocol (30 cycles) was the following: 95 °C 
for 45 sec, 55 °C for 60 sec, 72 °C for 60 sec. Each 25 µL reaction contained 1U of AmpliTaq DNA Polymerase 
(Lucigen, US) and 0.5 µM of each primer. The amplification products were visualized on agarose (2%) gel by load-
ing approximately half (10 µL) of each reaction per lane. The band of 466 bp indicated the transgenic genotype, 
whereas its absence indicated the WT genotype.
Primary hippocampal neurons. Primary neuronal cultures were prepared from hippocampi of embry-
onic day 15 Tg2576 and WT mouse embryos as previously described72 (Canzoniero et al., 1999) with some 
modifications. Briefly, pregnant animals were anesthetized and sacrificed by cervical dislocation. Hippocampal 
tissues from embryos were dissected in ice-cold dissecting medium (Hanks’ Balanced Salt Solution, HBSS, 
from Invitrogen, California, USA) supplemented with (in mM): 27 glucose, 20 sucrose, 4 NaHCO3, and cen-
trifuged; the resulting pellets were then mechanically dissociated with a fire polished glass pipette. Next, cells 
were resuspended in plating medium containing Eagle’s minimum essential medium (MEM, Earle’s salts in 
bicarbonate-free form, from Invitrogen, California, USA) supplemented with 5% fetal bovine serum, 5% horse 
serum (HS), 2 mM L-glutamine, 20 mM glucose, 26 mM NaHCO3, and plated on 35 mm culture dishes coated 
with poly(D)-lysine hydrobromide MolWt >300,000 (Sigma Aldrich, Milan, Italy), or onto 25 mm glass covers-
lips (Glaswarenfabrik Karl Hecht KG, Sondheim, Germany), coated with 100 μg/ml poly(D)-lysine hydrobromide 
MolWt 30,000–70,000 (Sigma Aldrich, Milan, Italy), at a density of one embryo hippocampi/1 ml. Three days 
after plating, non-neuronal cell growth was inhibited by adding 10 μM of cytosine β-D-arabinofuranoside (from 
Sigma Aldrich, Milan, Italy) Twenty-four hours after treatment, the plating medium was replaced with growth 
medium: MEM supplemented with 20 mM glucose, 26 mM NaHCO3, 2 mM L-glutamine and 10% HS). Neurons 
were cultured at 37 °C in a humidified 5% CO2 atmosphere. All the experiments were performed between 8–12 
days in vitro (DIV).
Solubilization of Aβ peptide and cellular treatment. The chemical constructs of Aβ peptides were 
synthesized by INBIOS (Naples, Italy) using the Aβ1–42 sequence of human APP and reversed sequence Aβ42-
1. This source yielded peptides with 95% purity, as revealed by high performance liquid chromatography and 
mass spectrometry. Lyophilized peptides were stored in sealed glass vials in desiccated containers at −20 °C. 
Prior to resuspension, each vial was allowed to equilibrate to room temperature for 30 min to avoid condensa-
tion upon opening the vial. The first step in resuspending the lyophilized peptide was treatment in 1, 1, 1, 3, 3, 
3-hexafluoro-2-propanol (HFIP; Sigma Aldrich, Milan, Italy). Each vial was diluted in 100% HFIP to 1 mM. The 
clear solution containing the dissolved peptide was then aliquoted in microcentrifuge tubes and dried under vac-
uum in a SpeedVac until complete elimination of the solvent and recovery of the dried powder. Immediately prior 
to use, the HFIP-treated aliquots were carefully and completely resuspended to 5 mM in anhydrous dimethyl sul-
foxide (Me2SO; Sigma Aldrich, Milan; Italy). Aβ1–42 and Aβ42-1 oligomers were prepared by diluting the peptides at 
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5 mM concentration in Me2SO to 100 µM in ice-cold cell culture medium (phenol red-free Ham’s F-12), by imme-
diately vortexing them for 30 sec, and finally by incubating them at 4 °C for 24 hours. After 24 hours, the solution 
containing the Aβ oligomers was centrifuged at 14000 rpm at 4 °C for 10 min. The supernatant, containing Aβ 
oligomers, was recovered, aliquoted, and stored at −20 °C73. Before all in vitro experiments, the pre-aggregated 
preparation of the Aβ1–42 was tested with rabbit monoclonal anti-Aβ antibody (Cell signaling, Massachusetts, 
USA), which recognizes an epitope within residues 17–42 of human Aβ. In particular, western blot analyses 
showed a specific band at ~8 kDa, corresponding to Aβ1–42 dimers, and a smear ranging from ~8 to ~15 kDa, 
comprising lower molecular weight intermediates (trimers), at the highest concentration of Aβ1–42 preparation 
(Supplementary Fig. 2A). Aβ1–42 exposure was carried out in growth medium at the final concentration of 0.1, 1 
and 5 μM for 1, 12, 24, and 48 hours, whereas Aβ42-1 has been used as negative control at the final concentration 
of 5 μM for 24 hours74.
Solutions for electrophysiological recordings. Primary hippocampal neurons were recorded at 8–12 
DIV. For whole-cell current-clamp recordings neurons were bathed in extracellular Ringer solution containing 
(in mM): 126 NaCl, 1.2 NaHPO4, 2.4 KCl, 2.4 CaCl2, 1.2 MgCl2, 10 glucose, and 18 NaHCO3 at pH 7.4 (NaOH). 
The pipette solution contained (in mM): 140 K-Gluconate, 2 MgCl2, 2 Na2ATP, 0.3 NaGTP, 10 HEPES (pH 7.2 
with KOH)75.
For whole-cell patch-clamp recordings neurons were bathed in extracellular solution containing (in mM): 140 
NaCl, 3 KCl, 20 TEA-Cl (tetraethylammonium chloride), 1 MgCl2, 1 CaCl2, 10 HEPES, 5 CsCl, 0.1 CdCl2, pH 7.30 
(with NaOH), and the osmolarity was 330 mOsmol/75. The pipette contained the following solutions (in mM): 
140 CsF, 10 NaCl, 1 EGTA, and 10 HEPES, pH 7.30 (with CsOH); osmolarity was adjusted to 316 mOsmol/L with 
dextrose75.
Electrophysiological recordings. Na+ currents in hippocampal neurons were recorded with the 
patch-clamp technique in whole cell configuration using the commercially available amplifier Axopatch 200 B 
and Digidata 1322 A interface (Molecular Devices). Data were acquired and analyzed using the pClamp software 
(version 9.0, Molecular Devices). Capacity transients were cancelled, and series resistance was compensated by 
85–90%. Leakage current was digitally subtracted on-line. Current recordings were taken using low resistance 
electrodes (1.4–2.3 MΩ), sampled at a rate of 100 kHz and filtered at 5 kHz. The cells were held at −120 mV and 
stepped to a range of potentials (−100 to +30 mV in 5 mV increments) for 100 ms each75. Possible changes in cell 
size were calculated by monitoring the capacitance of each cell membrane, which is directly related to membrane 
surface area and by expressing the current amplitude data as current densities (pA/pF). The capacitance of the 
membrane was calculated according to the following equation: Cm = τc•Io/ΔEm(1−I∞/Io), where Cm is the 
membrane capacitance, τc is the time constant of the membrane capacitance, Io is the maximum capacitance cur-
rent value, ΔEm is the amplitude of the voltage step, and I∞ is the amplitude of the steady-state current. 50 nM 
TTX (purchased from Alomone Labs, Jerusalem, Israel) was added to the extracellular bath solution to block 
endogenous NaV currents.
Current signals were acquired in gap-free modality using a Digidata 1322 A interface (Molecular Devides). 
Data were acquired and analyzed using the pClamp software (version 9.0, Molecular Devices).
Electrophysiology data analysis was performed using Clampfit software (version 9.0, Molecular Devices) and 
GraphPad Prism 6.02 software.
Spontaneous action potential (AP) activity was measured in WT and Tg2576 hippocampal neurons using the 
protocol previously described76,77. Importantly, sustained high-quality whole-cell recordings could be maintained 
for >15 minutes with a stable membrane potential and AP waveform, confirming that the presence of spontane-
ous APs was not the result of declining cell health. Spontaneous AP amplitude and frequency were determined 
using own computer program written in Java computer language78. Briefly, for each hippocampal neuron, the 
software calculated the AP mean ± SD during the baseline recording interval. This was used to define a cutoff 
identifying AP, which was set at mean AP ± 2 SD. Subsequently, the software identified as AP each value higher 
than this cutoff point. To quantify AP features in hippocampal neurons dissected from WT and Tg2576, the 
following parameters were determined: the amplitude, defined as the difference between transient AP and mean 
basal and the frequency, defined as the number of peaks divided by the duration of observation.
Preparations of hippocampal slices and field potential recordings. Extracellular field recordings 
were performed in acute horizontal hippocampal slices prepared from 3-month-old WT and Tg2576 mice using 
a procedure similar to that described by79 Sambri et al. In brief, all animals were deeply anesthetized and decapi-
tated. The brain was quickly removed from the skull and transferred into an ice-cold NMDG-based cutting solu-
tion containing (in mM): 93 N-methyl-D-glucamine, 2.5 KCl, 1.2 NaH2PO4, 30 NaHCO3, 20 HEPES, 25 glucose, 
5 ascorbic acid, 3 Na-pyruvate, 10 MgSO4·7H20, and 0.5 CaCl2·2H20. After a 2–3 min incubation, the frontal lobes 
and the cerebellum with the brainstem were removed with a razor blade and the brain was glued upside-down on 
the stage of a Leica VT1000S vibratome (Leica Microsystems Srl, Buccinasco, Milan, Italy) and cut into 450 μM 
tick horizontal slices. The slices were transferred into an interface recording chamber and allowed to equilibrate 
for 1 hour while being continuously superfused (5 ml/min) with ACSF at 32 °C, equilibrated at pH 7.4 with gas 
mixture (95% O2, 5% CO2), and containing (in mM): 124 NaCl, 2 KCl, 1.25 KH2PO4, 2 MgSO4, 2 CaCl2, 26 
NaHCO3 and 10 D-glucose. Epileptiform activity, which was elicited by adding 50 μM 4-AP to the superfusing 
ACSF solution, was recorded with an ACSF-filled borosilicate microelectrode (2–3 M Ω final resistance) con-
nected to the preamplifier probe of an EXT-02F extracellular amplifier (npi Electronic, Tamm, Germany). Data 
were digitized at 10 kHz with a Digidata 1322 A A/D converter (Molecular Devices, Sunnyvale CA, USA), col-
lected with pClamp 10, and analyzed with Clampfit 9 (Molecular Devices, Sunnyvale CA, USA). To calculate 
frequency, amplitude duration, and interval of the 4-AP-induced discharges, data were down-sampled to 1 kHz 
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and analyzed with Matlab R2017a (Mathworks, Natick, MA USA) using the ipeak7.7.1 package by T. O’Haver, 
which is freely available on the Mathworks file exchange website:
(https://it.mathworks.com/matlabcentral/fileexchange/23850ipeak?requestedDomain=true).
Anisomycin treatment. For the patch clamp experiments, hippocampal neurons were treated with 10 μg/
ml anisomycin for 30 min before the culture media was replaced with the bath solution without the drug and 
electrophysiological recordings were undertaken for the next 60 min38. Moreover, hippocampal slices were super-
fused with 100 μg/ml anisomycin for 1 hour to allow drug penetration into the slice before starting field potential 
recordings.
Western-blot analysis. To obtain total lysates for immunoblotting analyses, primary hippocampal neu-
rons were washed in phosphate buffered saline (PBS) and collected by gentle scraping in ice-cold RIPA buffer 
containing (in mM) 50 Tris pH 7.4, 100 NaCl, 1 EGTA, 1 PMSF, 1 sodium orthovanadate, 1 NaF, 0.5% NP-40, 
and 0.2% SDS supplemented with protease inhibitor cocktail II (Roche Diagnostic, Monza, Italy). Nitrocellulose 
membranes were incubated overnight with rabbit-polyclonal anti-NaV1.6 (1:500, Alomone Labs-Israel)22,80, 
anti-NaV1.2 (1:500, Alomone Labs-Israel)22 and anti-NaV1.1 antibodies (1:500, Alomone Labs-Israel)65, or mouse 
monoclonal anti-tubulin (1:3000, Sigma Aldrich, Milan, Italy). Immunoreactive bands were detected with the 
chemiluminescence system (Amersham-Pharmacia-Biosciences, UK). Films were developed with a stand-
ard photographic procedure and the quantitative analysis of detected bands was carried out by densitometric 
scanning.
Immunofluorescence and quantitative analyses. Confocal double immunofluorescence procedures 
in primary hippocampal neurons obtained from WT and Tg2576 mouse embryos were performed as previously 
described81. In brief, cell cultures were fixed in 4% paraformaldehyde in PBS for 30 min. After blockage with 
Rodent M Block (Biocare Medical, Concord, CA, USA) for 1 hour, cells were incubated with rabbit polyclonal 
anti-NaV1.6 antibody (1:2000 Alomone Labs, Israel) and mouse monoclonal anti-MAP2 antibody (1:2000, Sigma 
Aldrich, Milan, Italy) at 4 °C overnight for 24 hours. Subsequently, cells were incubated with a mixture of the 
fluorescent-labeled secondary antibodies: Alexa 488 conjugated anti-rabbit and Alexa 594-conjugated anti-mouse 
(Molecular Probes, Eugene, OR; dilution 1:200) for 1 hour at room temperature. Cell nuclei were stained with 
Hoechst-33258 (Sigma Aldrich, Milan, Italy). After the final wash, cells were mounted and coverslipped with 
Vectashield (Vector Labs, Burlingame, CA). Immunostaining of tissue sections were performed in 3-month-old 
WT and Tg2576 mice. Briefly, mice were deeply anesthetized with Zoletil 100 (zolazepam/tiletamine, 1:1, 10 mg/
kg, Laboratoire Virbac) and Xilor (xylazine 2%, 0.06 ml/kg, Bio98), and transcardially perfused with 4% (wt/
vol) paraformaldehyde in phosphate buffer82. Brains were cryoprotected in sucrose, frozen, and sectioned cor-
onally at 50 µm on a cryostat. After blocking with Rodent M block (Biocare Medical, Concord, USA), sections 
were incubated with rabbit polyclonal anti-NaV1.6 antibody (1:500 Alomone Labs, Israel) and mouse monoclonal 
anti-MAP2 antibody (1:500, Sigma Aldrich, Milan, Italy) at 4 °C overnight for 48 hours. Then, sections were incu-
bated with corresponding fluorescence-labeled secondary antibodies. Images were observed using a Zeiss LSM 
700 laser (Carl Zeiss) scanning confocal microscope. Single images were taken with an optical thickness of 0.7 µm 
and a resolution of 1,024 × 1,024.
Digital images were taken with 63x or 100x objective lens and identical laser power settings and exposure 
times were applied to all the photographs from each experimental set. For quantification of NaV1.6 puncta within 
the soma of neurons, images were first thresholded and subsequently the number of particles was automatically 
counted with a specific NIH Image function83.
naV1.6 Silencing RNA transfection. siRNA against NaV1.6 was purchased from Qiagen (Milan, Italy). 
One predesigned siRNA directed against mouse SCN8a transcript (GenBank accession number NM_001077499; 
Entrez Gene ID 20273) was tested (Mm_Scn8a_6 Flexitube siRNA, Cat.No SI02713956), which binds a coding 
sequence on NaV1.6 mRNA downstream of the transcription start site. The siRNA was transiently transfected 
using Lipofectamine 3000 (Thermo Fischer, Massachusetts, USA), at a final concentration of 50 nM in serum free 
OptiMEM medium (Invitrogen, California, USA) for 5 hours, at the end of which OptiMEM was replaced with 
growth medium. Gene-silencing efficiency of siRNA was determined 48 hours after transfection by electrophysi-
ological measurements and western blot analyses.
Statistics. GraphPad Prism 6.02 was used for statistical analyses (GraphPad Software, La Jolla, CA). The 
data are expressed as the mean ± S.E.M. of the values obtained from individual experiments. Statistical compar-
isons between groups were performed by Student’s t-test or one-way analysis of variance (ANOVA) followed by 
Bonferroni post hoc test or Newman–Keuls’ test; p < 0.05 was considered significant.
Ethics approval and consent to participate. Animals were handled in accordance with the International 
Guidelines for Animal Research and the experimental protocol was approved by the Animal Care and Use 
Committee of “Federico II” University of Naples.
Data Availability
Any data is available upon reasonable request.
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